Schachtschneider Andreas, Klein Stephanie, Marshall Kate
METALL+PLASTIC GmbH, Radolfzell, Germany;
OPTIMA pharma GmbH, Schwaebisch Hall, Germany; and.
PDA J Pharm Sci Technol. 2022 Jan-Feb;76(1):34-51. doi: 10.5731/pdajpst.2020.012294. Epub 2021 Jun 15.
An important prerequisite for aseptic production of pharmaceuticals is the appropriate reduction of microbiological contamination. Hydrogen peroxide is commonly applied as decontamination agent for such processes in barrier systems. The development and validation of the barrier decontamination cycles is usually performed with the use of biological indicators (). However, these indicators inherit certain drawbacks. A new type of indicators became available lately, based on the use of enzyme as a substance decomposed by hydrogen peroxide. There is no broad experience on the practical application of these enzyme indicators yet. Therefore, we investigated the practical use of enzyme indicators in comparison with biological indicators. To broaden the understanding on how these indicators might be used in practice, we provided an evaluation of indicator response variability and the correlation of enzyme indicator results to biological indicator results. In this study, we found the variability of the quantitative enzyme indicator reading to be < 30%, which is much smaller than the variability for spore enumeration of biological indicators (-50% to +300%). Further, we introduced a universal normalization approach to enable convenient comparison and evaluation of different enzyme indicator results. Finally, we discussed a new approach to establish a quantitative correlation between enzyme indicators and biological indicators with the use of threshold values to extrapolate theoretical biological indicator group results. We take the findings of this study as a basis for a suggestion on the practical application of enzyme indicators. We expect that the discussed possibilities of correlating enzyme indicator results to biological indicator results will allow the combined practical use of both indicator types. This would enable the continued application of proven approaches in new ways. Beyond this, the fast reading of enzyme indicators with the gain of significant quantitative information might result in faster and safer qualification and validation of pharmaceutical production equipment in the future.
药品无菌生产的一个重要前提是适当减少微生物污染。过氧化氢通常用作屏障系统中此类过程的去污剂。屏障去污循环的开发和验证通常使用生物指示剂进行。然而,这些指示剂存在某些缺点。最近出现了一种新型指示剂,基于使用酶作为被过氧化氢分解的物质。目前对于这些酶指示剂的实际应用还没有广泛的经验。因此,我们将酶指示剂与生物指示剂进行比较,研究了酶指示剂的实际应用。为了更深入了解这些指示剂在实际中如何使用,我们对指示剂响应变异性以及酶指示剂结果与生物指示剂结果的相关性进行了评估。在本研究中,我们发现定量酶指示剂读数的变异性<30%,这远小于生物指示剂孢子计数的变异性(-50%至+300%)。此外,我们引入了一种通用的归一化方法,以便于对不同的酶指示剂结果进行比较和评估。最后,我们讨论了一种新方法,通过使用阈值来推断理论生物指示剂组结果,从而在酶指示剂和生物指示剂之间建立定量相关性。我们将本研究的结果作为酶指示剂实际应用建议的基础。我们期望所讨论的将酶指示剂结果与生物指示剂结果相关联的可能性能够使两种指示剂类型联合实际使用。这将使已验证的方法能够以新的方式继续应用。除此之外,酶指示剂的快速读数以及获得重要的定量信息可能会在未来使药品生产设备的鉴定和验证更快、更安全。